Evidence map›Paper›PMID 40395501›Full record

ArticleBioinformatics advances2025

Benchmarking accelerated next-generation sequencing analysis pipelines.

Pubudu Saneth Samarakoon, Ghislain Fournous, Lars T Hansen, Ashen Wijesiri, Sen Zhao, Rodriguez Alex A, Tarak Nath Nandi, Ravi Madduri, Alexander D Rowe, Gard Thomassen and 2 more

Abstract read
In one paragraph

Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pubudu Saneth SamarakoonScientific Computing Services, Division for Research, Dissemination and Education, University of Oslo, Oslo, 0373, Norway.ORCID https://orcid.org/0000-0001-7856-1471
Ghislain FournousNorwegian National Unit for Newborn Screening, Division for Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, 0450, Norway.
Lars T HansenScientific Computing Services, Division for Research, Dissemination and Education, University of Oslo, Oslo, 0373, Norway.
Ashen WijesiriScientific Computing Services, Division for Research, Dissemination and Education, University of Oslo, Oslo, 0373, Norway.
Sen ZhaoDepartment of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, 0424, Norway.ORCID https://orcid.org/0009-0009-3463-7732
Rodriguez Alex AData Science and Learning, Argonne National Laboratory, University of Chicago, Chicago, IL, 60439, United States.
Tarak Nath NandiData Science and Learning, Argonne National Laboratory, University of Chicago, Chicago, IL, 60439, United States.
Ravi MadduriData Science and Learning, Argonne National Laboratory, University of Chicago, Chicago, IL, 60439, United States.
Alexander D RoweNorwegian National Unit for Newborn Screening, Division for Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, 0450, Norway.
Gard ThomassenDivision for Research, Dissemination and Education, University of Oslo, Oslo, 0373, Norway.
Eivind HovigDepartment of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, 0424, Norway.ORCID https://orcid.org/0000-0002-9103-1077
Sabry RazickScientific Computing Services, Division for Research, Dissemination and Education, University of Oslo, Oslo, 0373, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Industry-standard central processing unit (CPU)-based next-generation sequencing (NGS) analysis tools have led to longer runtimes, affecting their utility in time-sensitive clinical practices and population-scale research studies. To address this, researchers have developed accelerated NGS platforms like DRAGEN and Parabricks, which have significantly reduced runtimes-from days to hours. However, these studies have evaluated accelerated platforms independently without sufficiently assessing computational resource usage or thoroughly investigating speedup scalability, a gap our study is designed to address. Results: Corroborating previous studies, accelerated pipelines demonstrated shorter runtimes than CPU-only approaches, with Parabricks-H100 demonstrating the highest speedups, followed by DRAGEN. In mapping, DRAGEN outperformed Parabricks (L4 and A100) and matched H100 speedups. Parabricks (A100 and H100) variant calling demonstrated higher speedups than DRAGEN. Moreover, DRAGEN and Parabricks-H100 mapping showed positive trends in the coverage-based scalability analysis, while other configurations failed to scale effectively. Our profiler analysis provided new insights into the relationships between Parabricks' performances and resource usage patterns, revealing its potential for further improvements. Our findings and cost comparison help researchers select accelerated platforms based on coverage needs, timeframes, and budget, while suggesting optimization strategies. Availability and implementation: Datasets are described in the 'Data availability' section. Our NGS pipelines are available at https://github.com/NAICNO/accelerated_genomics.

Identifiers

PMID40395501
PMCPMC12092081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.